Industry: Medical Devices & Consumables
Published Date: 2026-01-09
Pages: 152 Pages
Report ld: 5633929
Request Sample
Customized Report
Long-Read Sequencing Market Size(US$)

CAGR 2026-2032
21.6%
Market Size,2032
USD 3,283
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Long-Read Sequencing market was valued at US$ 850 million in 2025 and is anticipated to reach US$ 3283 million by 2032, at a CAGR of 21.6% from 2026 to 2032.
Long-read sequencing is a form of next-generation sequencing (NGS) that has technical advantages over short-read sequencing for the detection of specific types of genetic variation. It can sequence long strands of DNA or RNA in one go, without breaking it up into smaller fragments.
The North American market for Long-Read Sequencing is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Long-Read Sequencing is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Long-Read Sequencing in Research Institutes is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Long-Read Sequencing include Oxford Nanopore, Agilent Technologies, Thermo Fisher Scientific, QIAGEN, PacBio, Illumina, Takara Bio, 10X Genomics, Danaher, Azenta US, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Long-Read Sequencing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Long-Read Sequencing. The Long-Read Sequencing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Long-Read Sequencing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Long-Read Sequencing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Long-Read Sequencing companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long-Read Sequencing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Nanopore Sequencing
1.2.3 Single-molecule Real-time Sequencing
1.2.4 Synthetic Long-read Sequencing
1.3 Market by Application
1.3.1 Global Long-Read Sequencing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Research Institutes
1.3.3 Hospitals
1.3.4 Pharmaceutical
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Long-Read Sequencing Market Perspective (2021–2032)
2.2 Global Long-Read Sequencing Growth Trends by Region
2.2.1 Global Long-Read Sequencing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Long-Read Sequencing Historic Market Size by Region (2021–2026)
2.2.3 Long-Read Sequencing Forecasted Market Size by Region (2027–2032)
2.3 Long-Read Sequencing Market Dynamics
2.3.1 Long-Read Sequencing Industry Trends
2.3.2 Long-Read Sequencing Market Drivers
2.3.3 Long-Read Sequencing Market Challenges
2.3.4 Long-Read Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long-Read Sequencing Players by Revenue
3.1.1 Global Top Long-Read Sequencing Players by Revenue (2021–2026)
3.1.2 Global Long-Read Sequencing Revenue Market Share by Players (2021–2026)
3.2 Global Top Long-Read Sequencing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Long-Read Sequencing Revenue
3.4 Global Long-Read Sequencing Market Concentration Ratio
3.4.1 Global Long-Read Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long-Read Sequencing Revenue in 2025
3.5 Global Key Players of Long-Read Sequencing Head Offices and Areas Served
3.6 Global Key Players of Long-Read Sequencing, Products and Applications
3.7 Global Key Players of Long-Read Sequencing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Long-Read Sequencing Breakdown Data by Type
4.1 Global Long-Read Sequencing Historic Market Size by Type (2021–2026)
4.2 Global Long-Read Sequencing Forecasted Market Size by Type (2027–2032)
5 Long-Read Sequencing Breakdown Data by Application
5.1 Global Long-Read Sequencing Historic Market Size by Application (2021–2026)
5.2 Global Long-Read Sequencing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Long-Read Sequencing Market Size (2021–2032)
6.2 North America Long-Read Sequencing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Long-Read Sequencing Market Size by Country (2021–2026)
6.4 North America Long-Read Sequencing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Long-Read Sequencing Market Size (2021–2032)
7.2 Europe Long-Read Sequencing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Long-Read Sequencing Market Size by Country (2021–2026)
7.4 Europe Long-Read Sequencing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Long-Read Sequencing Market Size (2021–2032)
8.2 Asia-Pacific Long-Read Sequencing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Long-Read Sequencing Market Size by Region (2021–2026)
8.4 Asia-Pacific Long-Read Sequencing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Long-Read Sequencing Market Size (2021–2032)
9.2 Latin America Long-Read Sequencing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Long-Read Sequencing Market Size by Country (2021–2026)
9.4 Latin America Long-Read Sequencing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long-Read Sequencing Market Size (2021–2032)
10.2 Middle East & Africa Long-Read Sequencing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Long-Read Sequencing Market Size by Country (2021–2026)
10.4 Middle East & Africa Long-Read Sequencing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Oxford Nanopore
11.1.1 Oxford Nanopore Company Details
11.1.2 Oxford Nanopore Business Overview
11.1.3 Oxford Nanopore Long-Read Sequencing Introduction
11.1.4 Oxford Nanopore Revenue in Long-Read Sequencing Business (2021–2026)
11.1.5 Oxford Nanopore Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Long-Read Sequencing Introduction
11.2.4 Agilent Technologies Revenue in Long-Read Sequencing Business (2021–2026)
11.2.5 Agilent Technologies Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Long-Read Sequencing Introduction
11.3.4 Thermo Fisher Scientific Revenue in Long-Read Sequencing Business (2021–2026)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 QIAGEN
11.4.1 QIAGEN Company Details
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Long-Read Sequencing Introduction
11.4.4 QIAGEN Revenue in Long-Read Sequencing Business (2021–2026)
11.4.5 QIAGEN Recent Development
11.5 PacBio
11.5.1 PacBio Company Details
11.5.2 PacBio Business Overview
11.5.3 PacBio Long-Read Sequencing Introduction
11.5.4 PacBio Revenue in Long-Read Sequencing Business (2021–2026)
11.5.5 PacBio Recent Development
11.6 Illumina
11.6.1 Illumina Company Details
11.6.2 Illumina Business Overview
11.6.3 Illumina Long-Read Sequencing Introduction
11.6.4 Illumina Revenue in Long-Read Sequencing Business (2021–2026)
11.6.5 Illumina Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Details
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio Long-Read Sequencing Introduction
11.7.4 Takara Bio Revenue in Long-Read Sequencing Business (2021–2026)
11.7.5 Takara Bio Recent Development
11.8 10X Genomics
11.8.1 10X Genomics Company Details
11.8.2 10X Genomics Business Overview
11.8.3 10X Genomics Long-Read Sequencing Introduction
11.8.4 10X Genomics Revenue in Long-Read Sequencing Business (2021–2026)
11.8.5 10X Genomics Recent Development
11.9 Danaher
11.9.1 Danaher Company Details
11.9.2 Danaher Business Overview
11.9.3 Danaher Long-Read Sequencing Introduction
11.9.4 Danaher Revenue in Long-Read Sequencing Business (2021–2026)
11.9.5 Danaher Recent Development
11.10 Azenta US
11.10.1 Azenta US Company Details
11.10.2 Azenta US Business Overview
11.10.3 Azenta US Long-Read Sequencing Introduction
11.10.4 Azenta US Revenue in Long-Read Sequencing Business (2021–2026)
11.10.5 Azenta US Recent Development
11.11 Revvity
11.11.1 Revvity Company Details
11.11.2 Revvity Business Overview
11.11.3 Revvity Long-Read Sequencing Introduction
11.11.4 Revvity Revenue in Long-Read Sequencing Business (2021–2026)
11.11.5 Revvity Recent Development
11.12 New England Biolabs
11.12.1 New England Biolabs Company Details
11.12.2 New England Biolabs Business Overview
11.12.3 New England Biolabs Long-Read Sequencing Introduction
11.12.4 New England Biolabs Revenue in Long-Read Sequencing Business (2021–2026)
11.12.5 New England Biolabs Recent Development
11.13 BaseClear
11.13.1 BaseClear Company Details
11.13.2 BaseClear Business Overview
11.13.3 BaseClear Long-Read Sequencing Introduction
11.13.4 BaseClear Revenue in Long-Read Sequencing Business (2021–2026)
11.13.5 BaseClear Recent Development
11.14 Element Biosciences
11.14.1 Element Biosciences Company Details
11.14.2 Element Biosciences Business Overview
11.14.3 Element Biosciences Long-Read Sequencing Introduction
11.14.4 Element Biosciences Revenue in Long-Read Sequencing Business (2021–2026)
11.14.5 Element Biosciences Recent Development
11.15 CD Genomics
11.15.1 CD Genomics Company Details
11.15.2 CD Genomics Business Overview
11.15.3 CD Genomics Long-Read Sequencing Introduction
11.15.4 CD Genomics Revenue in Long-Read Sequencing Business (2021–2026)
11.15.5 CD Genomics Recent Development
11.16 Sage Sciences
11.16.1 Sage Sciences Company Details
11.16.2 Sage Sciences Business Overview
11.16.3 Sage Sciences Long-Read Sequencing Introduction
11.16.4 Sage Sciences Revenue in Long-Read Sequencing Business (2021–2026)
11.16.5 Sage Sciences Recent Development
11.17 EdenRoc Sciences
11.17.1 EdenRoc Sciences Company Details
11.17.2 EdenRoc Sciences Business Overview
11.17.3 EdenRoc Sciences Long-Read Sequencing Introduction
11.17.4 EdenRoc Sciences Revenue in Long-Read Sequencing Business (2021–2026)
11.17.5 EdenRoc Sciences Recent Development
11.18 BGI Group
11.18.1 BGI Group Company Details
11.18.2 BGI Group Business Overview
11.18.3 BGI Group Long-Read Sequencing Introduction
11.18.4 BGI Group Revenue in Long-Read Sequencing Business (2021–2026)
11.18.5 BGI Group Recent Development
11.19 Novogene
11.19.1 Novogene Company Details
11.19.2 Novogene Business Overview
11.19.3 Novogene Long-Read Sequencing Introduction
11.19.4 Novogene Revenue in Long-Read Sequencing Business (2021–2026)
11.19.5 Novogene Recent Development
11.20 Grandomics
11.20.1 Grandomics Company Details
11.20.2 Grandomics Business Overview
11.20.3 Grandomics Long-Read Sequencing Introduction
11.20.4 Grandomics Revenue in Long-Read Sequencing Business (2021–2026)
11.20.5 Grandomics Recent Development
11.21 Wuhan Beina Technology
11.21.1 Wuhan Beina Technology Company Details
11.21.2 Wuhan Beina Technology Business Overview
11.21.3 Wuhan Beina Technology Long-Read Sequencing Introduction
11.21.4 Wuhan Beina Technology Revenue in Long-Read Sequencing Business (2021–2026)
11.21.5 Wuhan Beina Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Long-Read Sequencing market is projected to grow from US$ 850 million in 2025 to US$ 3283 million by 2032, at a CAGR of 21.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 172
USD 4900.00
(Single User License)
The global Long-Read Sequencing market size was US$ 850 million in 2025 and is forecast to reach a readjusted size of US$ 3283 million by 2032 with a CAGR of 21.6% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 120
USD 4250.00
(Single User License)
The global market for Long-Read Sequencing was estimated to be worth US$ 850 million in 2025 and is projected to reach US$ 3283 million, growing at a CAGR of 21.6% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 157
USD 3950.00
(Single User License)
The global Long-Read Sequencing market is projected to grow from US$ 712 million in 2024 to US$ 2749 million by 2031, at a CAGR of 21.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 162
USD 4900.00
(Single User License)
The global Long-Read Sequencing market size was US$ 712 million in 2024 and is forecast to a readjusted size of US$ 2749 million by 2031 with a CAGR of 21.6% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 112
USD 4250.00
(Single User License)
The global market for Long-Read Sequencing was estimated to be worth US$ 712 million in 2024 and is forecast to a readjusted size of US$ 2749 million by 2031 with a CAGR of 21.6% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 149
USD 3950.00
(Single User License)
The global market for Long-Read Sequencing was valued at US$ 712 million in the year 2024 and is projected to reach a revised size of US$ 2749 million by 2031, growing at a CAGR of 21.6% during the forecast period.
Published Date: 2025-03-10
Pages: 102
USD 2900.00
(Single User License)
Long-read sequencing is a form of next-generation sequencing (NGS) that has technical advantages over short-read sequencing for the detection of specific types of genetic variation. It can sequence long strands of DNA or RNA in one go, without breaking it up into smaller fragments.
Published Date: 2024-08-14
Pages: 136
USD 4350.00
(Single User License)
Long-read sequencing is a form of next-generation sequencing (NGS) that has technical advantages over short-read sequencing for the detection of specific types of genetic variation. It can sequence long strands of DNA or RNA in one go, without breaking it up into smaller fragments.
Published Date: 2024-08-14
Pages: 107
USD 2900.00
(Single User License)
Long-read sequencing is a form of next-generation sequencing (NGS) that has technical advantages over short-read sequencing for the detection of specific types of genetic variation. It can sequence long strands of DNA or RNA in one go, without breaking it up into smaller fragments.
Published Date: 2024-08-14
Pages: 175
USD 4900.00
(Single User License)
The global Long-Read Sequencing market is projected to grow from US$ 850 million in 2025 to US$ 3283 million by 2032, at a CAGR of 21.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 172
The global Long-Read Sequencing market size was US$ 850 million in 2025 and is forecast to reach a readjusted size of US$ 3283 million by 2032 with a CAGR of 21.6% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 120
The global market for Long-Read Sequencing was estimated to be worth US$ 850 million in 2025 and is projected to reach US$ 3283 million, growing at a CAGR of 21.6% from 2026 to 2032.
Published: 2026-01-09
Pages: 157
The global Long-Read Sequencing market is projected to grow from US$ 712 million in 2024 to US$ 2749 million by 2031, at a CAGR of 21.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 162
The global Long-Read Sequencing market size was US$ 712 million in 2024 and is forecast to a readjusted size of US$ 2749 million by 2031 with a CAGR of 21.6% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 112
The global market for Long-Read Sequencing was estimated to be worth US$ 712 million in 2024 and is forecast to a readjusted size of US$ 2749 million by 2031 with a CAGR of 21.6% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 149
The global market for Long-Read Sequencing was valued at US$ 712 million in the year 2024 and is projected to reach a revised size of US$ 2749 million by 2031, growing at a CAGR of 21.6% during the forecast period.
Published: 2025-03-10
Pages: 102
Long-read sequencing is a form of next-generation sequencing (NGS) that has technical advantages over short-read sequencing for the detection of specific types of genetic variation. It can sequence long strands of DNA or RNA in one go, without breaking it up into smaller fragments.
Published: 2024-08-14
Pages: 136
Long-read sequencing is a form of next-generation sequencing (NGS) that has technical advantages over short-read sequencing for the detection of specific types of genetic variation. It can sequence long strands of DNA or RNA in one go, without breaking it up into smaller fragments.
Published: 2024-08-14
Pages: 107
Long-read sequencing is a form of next-generation sequencing (NGS) that has technical advantages over short-read sequencing for the detection of specific types of genetic variation. It can sequence long strands of DNA or RNA in one go, without breaking it up into smaller fragments.
Published: 2024-08-14
Pages: 175
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now